Morisset Valerie

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Morisset Valerie's trades of Climb Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
46.86
Quantity 75,416 -13.7%
Value US$1,036,940
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
98.48
Quantity 75,918 +14.5%
Value US$1,799,875
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
309.58
Quantity 15,890 -42.9%
Value US$2,689,669
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
7.09
Quantity 10,201 -6.4%
Value US$72,325
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
6.93
Quantity 38,576 -19.4%
Value US$267,332
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
6.91
Quantity 3,207 -1.6%
Value US$22,160
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
7.13
Quantity 50,000 -19.8%
Value US$356,500
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
7.01
Quantity 42,377 -14.4%
Value US$297,063
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
7.07
Quantity 50,000 -14.5%
Value US$353,500
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
7.11
Quantity 50,000 -12.7%
Value US$355,500
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
6.83
Quantity 50,000 -11.2%
Value US$341,500
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
6.66
Quantity 5,931 -1.3%
Value US$39,500
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
7.06
Quantity 12,342 -2.7%
Value US$87,135
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
6.76
Quantity 50,000 -9.7%
Value US$338,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-23 2024-07-22
US Climb Bio Inc (CLYM)
S Sale
75,416 -13.7%
46.86
US$1,036,940 		75,416 -13.7% 46.86 US$1,036,940
2024-07-23 2024-07-22
US Climb Bio Inc (CLYM)
S Sale
75,918 +14.5%
98.48
US$1,799,875 		75,918 +14.5% 98.48 US$1,799,875
2024-07-23 2024-07-19
US Climb Bio Inc (CLYM)
S Sale
15,890 -42.9%
309.58
US$2,689,669 		15,890 -42.9% 309.58 US$2,689,669
2024-07-23 2024-07-19
US Climb Bio Inc (CLYM)
S Sale
10,201 -6.4%
7.09
US$72,325 		10,201 -6.4% 7.09 US$72,325
2024-07-19 2024-07-18
US Climb Bio Inc (CLYM)
S Sale
38,576 -19.4%
6.93
US$267,332 		38,576 -19.4% 6.93 US$267,332
2024-07-19 2024-07-17
US Climb Bio Inc (CLYM)
S Sale
3,207 -1.6%
6.91
US$22,160 		3,207 -1.6% 6.91 US$22,160
2024-07-17 2024-07-16
US Climb Bio Inc (CLYM)
S Sale
50,000 -19.8%
7.13
US$356,500 		50,000 -19.8% 7.13 US$356,500
2024-07-16 2024-07-15
US Climb Bio Inc (CLYM)
S Sale
42,377 -14.4%
7.01
US$297,063 		42,377 -14.4% 7.01 US$297,063
2024-07-16 2024-07-12
US Climb Bio Inc (CLYM)
S Sale
50,000 -14.5%
7.07
US$353,500 		50,000 -14.5% 7.07 US$353,500
2024-07-11 2024-07-11
US Climb Bio Inc (CLYM)
S Sale
50,000 -12.7%
7.11
US$355,500 		50,000 -12.7% 7.11 US$355,500
2024-07-11 2024-07-10
US Climb Bio Inc (CLYM)
S Sale
50,000 -11.2%
6.83
US$341,500 		50,000 -11.2% 6.83 US$341,500
2024-07-11 2024-07-09
US Climb Bio Inc (CLYM)
S Sale
5,931 -1.3%
6.66
US$39,500 		5,931 -1.3% 6.66 US$39,500
2024-07-09 2024-07-05
US Climb Bio Inc (CLYM)
S Sale
12,342 -2.7%
7.06
US$87,135 		12,342 -2.7% 7.06 US$87,135
2024-07-03 2024-07-03
US Climb Bio Inc (CLYM)
S Sale
50,000 -9.7%
6.76
US$338,000 		50,000 -9.7% 6.76 US$338,000